These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 25794589)
1. [Superficial bladder cancer: Transurethral resection and instillation therapy]. Schenck M; Lümmen G Urologe A; 2015 Apr; 54(4):499-503. PubMed ID: 25794589 [TBL] [Abstract][Full Text] [Related]
2. [Diagnostics of nonmuscle-invasive urothelial cell carcinoma of the bladder]. Tschirdewahn S; Vom Dorp F Urologe A; 2015 Apr; 54(4):480-3. PubMed ID: 25784270 [TBL] [Abstract][Full Text] [Related]
3. Diffusion-weighted magnetic resonance imaging in follow-up of superficial urinary bladder carcinoma after transurethral resection: initial experience. El-Assmy A; Abou-El-Ghar ME; Refaie HF; Mosbah A; El-Diasty T BJU Int; 2012 Dec; 110(11 Pt B):E622-7. PubMed ID: 22757606 [TBL] [Abstract][Full Text] [Related]
4. T1 GIII bladder cancer. Management with transurethral resection only. Zungri E; Martinez L; Da Silva EA; Pesqueira D; de la Fuente Buceta A; Pereiro B Eur Urol; 1999 Nov; 36(5):380-4; discussion 384-5. PubMed ID: 10516446 [TBL] [Abstract][Full Text] [Related]
5. Use of bipolar energy for transurethral resection of superficial bladder tumors: long-term results. Pu XY; Wang HP; Wu YL; Wang XH J Endourol; 2008 Mar; 22(3):545-9. PubMed ID: 18257673 [TBL] [Abstract][Full Text] [Related]
6. The importance of transurethral resection of bladder tumor in the management of nonmuscle invasive bladder cancer: a systematic review of novel technologies. Richards KA; Smith ND; Steinberg GD J Urol; 2014 Jun; 191(6):1655-64. PubMed ID: 24518761 [TBL] [Abstract][Full Text] [Related]
7. Safety and Efficacy of En Bloc Transurethral Resection With 1.9 µm Vela Laser for Treatment of Non-Muscle-invasive Bladder Cancer. Xu H; Ma J; Chen Z; Yang J; Yuan H; Wang T; Liu J; Yang W; Ye Z Urology; 2018 Mar; 113():246-250. PubMed ID: 29198850 [TBL] [Abstract][Full Text] [Related]
8. Can a second resection be avoided after initial thulium laser endoscopic en bloc resection for non-muscle invasive bladder cancer? A retrospective single-center study of 251 patients. Zhou W; Wang W; Wu W; Yan T; Du G; Liu H BMC Urol; 2020 Mar; 20(1):30. PubMed ID: 32188429 [TBL] [Abstract][Full Text] [Related]
9. Endoscopic therapy of superficial bladder cancer in high-risk patients: Holmium laser versus transurethral resection. Muraro GB; Grifoni R; Spazzafumo L Surg Technol Int; 2005; 14():222-6. PubMed ID: 16525976 [TBL] [Abstract][Full Text] [Related]
10. [Prospective study of effectiveness. Reoperation (re-TUR) in superficial bladder carcinoma]. Vögeli TA; Grimm MO; Simon X; Ackermann R Urologe A; 2002 Sep; 41(5):470-4. PubMed ID: 12426865 [TBL] [Abstract][Full Text] [Related]
11. [Transurethral resection of bladder tumors and prostate enlargement in physiological saline solution (TURIS). A prospective study]. Rose A; Suttor S; Goebell PJ; Rossi R; Rübben H Urologe A; 2007 Sep; 46(9):1148-50. PubMed ID: 17619851 [TBL] [Abstract][Full Text] [Related]
12. Retrospective analysis of transurethral resection, second-look resection, and long-term chemo-metaphylaxis for superficial bladder cancer: indications and efficacy of a differentiated approach. Schulze M; Stotz N; Rassweiler J J Endourol; 2007 Dec; 21(12):1533-41. PubMed ID: 18186695 [TBL] [Abstract][Full Text] [Related]
13. Risk factors for positive findings in patients with high-grade T1 bladder cancer treated with transurethral resection of bladder tumour (TUR) and bacille Calmette-Guérin therapy and the decision for a repeat TUR. Orsola A; Cecchini L; Raventós CX; Trilla E; Planas J; Landolfi S; de Torres I; Morote J BJU Int; 2010 Jan; 105(2):202-7. PubMed ID: 19558557 [TBL] [Abstract][Full Text] [Related]
14. [Endoscopic resection in the treatment of infiltrative bladder tumors. The analysis of a nonselected group of 111 cases]. Proca E; Lucan M; Sinescu I; Georgescu G Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir; 1989; 38(2):81-93. PubMed ID: 2528184 [TBL] [Abstract][Full Text] [Related]
15. Surgical management of noninvasive bladder cancer (stages Ta/T1/CIS). Holzbeierlein JM; Smith JA Urol Clin North Am; 2000 Feb; 27(1):15-24, vii-viii. PubMed ID: 10696241 [TBL] [Abstract][Full Text] [Related]
16. [Comparison of endoscopic irsection and vaporization for superficial bladder cancer]. Wang WM; Ye M; Chen JH; Zhang L; Kong L; Zhu YJ Zhonghua Zhong Liu Za Zhi; 2003 May; 25(3):292-4. PubMed ID: 12839699 [TBL] [Abstract][Full Text] [Related]
17. Safety and side effects of immediate instillation of apaziquone following transurethral resection in patients with nonmuscle invasive bladder cancer. Hendricksen K; Gleason D; Young JM; Saltzstein D; Gershman A; Lerner S; Witjes JA J Urol; 2008 Jul; 180(1):116-20. PubMed ID: 18485407 [TBL] [Abstract][Full Text] [Related]
18. Lymphovascular invasion of urothelial cancer in matched transurethral bladder tumor resection and radical cystectomy specimens. Kunju LP; You L; Zhang Y; Daignault S; Montie JE; Lee CT J Urol; 2008 Nov; 180(5):1928-32; discussion 1932. PubMed ID: 18801529 [TBL] [Abstract][Full Text] [Related]
19. The role of endoscopic bladder tumour assessment in the management of patients subjected to transurethral bladder tumour resection. Skrzypczyk MA; Nyk Ł; Szostek P; Szempliński S; Borówka A; Dobruch J Eur J Cancer Care (Engl); 2017 Mar; 26(2):. PubMed ID: 26714143 [TBL] [Abstract][Full Text] [Related]